Mersana Therapeutics is developing novel antibody-drug conjugates targeting a heretofore untapped immune checkpoint, as well as HER2 from another angle. The company has an operational runway of 6 ...

The last time I wrote about Larimar Therapeutics, Inc. (NASDAQ:LRMR) it was in a Seeking Alpha article entitled "Larimar: Stronger Buy Now More Than Ever After Partial Clinical Hold Completely ...

Chimeric Therapeutics Ltd is a biotechnology company engaged in developing a cancer cell therapy drug. Its technology CLTX-CAR T uses chlorotoxin, a peptide discovered in scorpion venom, as the ...

Two primary interests have driven research into tick salivary secretions: the search for suitable pathogen transmission blocking or “anti-tick” vaccine candidates and the search for novel therapeutics ...

The Olson Lab’s current work focuses on discovering novel therapeutics for pediatric cancers and, more broadly, on discovering protein/peptide therapeutics for a wide range of pediatric diseases. Ex ...

According to researchers in the Beeton lab at Baylor College of Medicine, the scorpion venom component, iberiotoxin, which can reduce the severity of rheumatoid arthritis, may be used as a treatment ...

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other ...

Markets News, December 31, 2024: Stocks Close Out a Strong Year on a Weak Note; Dow Posts Biggest Monthly Loss in More Than Two Years ...

Abstract The innovation timeline is expensive, risky, competitive, time-consuming, and labor-intensive. In order to overcome such challenges and optimize financial resources, pharmaceutical companies ...